Taiyen Biotech Co., Ltd. (TPE:1737)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.55
-0.15 (-0.47%)
Mar 26, 2026, 1:30 PM CST

Taiyen Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,3106,3406,4906,8406,4906,640
Market Cap Growth
-3.52%-2.31%-5.12%5.39%-2.26%1.53%
Enterprise Value
4,6904,8004,9915,4054,8665,217
Last Close Price
31.5531.7031.1931.7228.8028.18
PE Ratio
15.8515.8617.4722.7715.2116.89
PS Ratio
1.911.922.002.011.801.62
PB Ratio
0.930.930.971.040.971.02
P/TBV Ratio
0.930.930.981.061.001.05
P/FCF Ratio
47.8448.0718.4160.5919.4031.43
P/OCF Ratio
14.6014.679.8315.0511.1811.07
EV/Sales Ratio
1.421.451.541.591.351.27
EV/EBITDA Ratio
6.526.768.8910.627.747.37
EV/EBIT Ratio
9.8910.1214.0816.8110.939.86
EV/FCF Ratio
35.5636.3914.1647.8814.5424.69
Debt / Equity Ratio
0.020.020.030.030.020.06
Debt / EBITDA Ratio
0.170.170.360.420.210.55
Debt / FCF Ratio
0.950.950.581.950.411.86
Net Debt / Equity Ratio
-0.24-0.24-0.26-0.25-0.26-0.26
Net Debt / EBITDA Ratio
-2.28-2.28-3.08-3.18-2.78-2.38
Net Debt / FCF Ratio
-12.28-12.28-4.91-14.34-5.22-7.99
Asset Turnover
0.400.400.390.410.430.50
Inventory Turnover
4.894.894.675.365.837.66
Quick Ratio
2.382.382.102.292.772.18
Current Ratio
2.872.872.512.753.342.60
Return on Equity (ROE)
5.84%5.84%4.80%3.29%6.49%6.40%
Return on Assets (ROA)
3.56%3.56%2.65%2.43%3.33%4.07%
Return on Invested Capital (ROIC)
7.34%7.46%5.27%4.31%7.36%9.00%
Return on Capital Employed (ROCE)
6.50%6.50%4.90%4.50%6.10%7.40%
Earnings Yield
6.34%6.31%5.73%4.39%6.58%5.92%
FCF Yield
2.09%2.08%5.43%1.65%5.16%3.18%
Dividend Yield
4.42%4.42%4.17%3.78%5.21%5.32%
Payout Ratio
65.02%65.02%64.60%99.87%70.31%68.66%
Buyback Yield / Dilution
-0.04%-0.04%-0.06%0.08%-0.05%-
Total Shareholder Return
4.39%4.38%4.11%3.87%5.16%5.32%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.